| Synonyms: | |
| Status: | Approved (2021) |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| ATC: | C10AX16 |
| UNII: | UOW2C71PG5 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cardiovascular Diseases | 4 | D002318 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
| Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
| Acute Coronary Syndrome | 3 | D054058 | ClinicalTrials |
| Hyperlipidemias | 1 | D006949 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1639324-58-5 |
| ChEMBL | CHEMBL3990033 |
| FDA SRS | UOW2C71PG5 |
CONTENTS